Insulin therapy can enhance the efficacy of new anti-inflammatory drugs, potentially reducing chronic inflammation in diabetic patients and improving overall glucose control.

Combining insulin with emerging anti-inflammatory treatments might target both blood sugar and inflammatory pathways, possibly leading to better diabetes management and fewer complications.